Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives-Reference-Cited by-同舟云学术

Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives

Published:2016-05 Issue: Volume:113 Page:50-62
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Eldehna Wagdy M.,Abou-Seri Sahar M.,El Kerdawy Ahmed M.,Ayyad Rezk R.,Hamdy Abdallah M.,Ghabbour Hazem A.,Ali Mamdouh M.,A. Abou El Ella Dalal

Funder

Research Group Project

National Institutes of Health National Center for Research Resources

National Institute of General Medical Sciences

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference40 articles.

1. Cancer Drug Discovery and Development: Antiangiogenic Agents in cancer Therapy;Dewhirst,2007

2. Angiogenesis in cancer and other diseases

3. Transplacental Carcinogenesis by Stilbestrol

4. Mechanisms of angiogenesis and arteriogenesis

5. Vascular endothelial growth factor (VEGF) signaling in tumor progression

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beta-1 Receptor (β1) in the Heart Specific Indicate to Stereoselectivity;Archives of Pharmacy and Pharmaceutical Sciences;2024-07-10

2. QSAR Based Drug Repurposing: A New Paradigm in Breast Cancer Research;Indian Journal of Pharmaceutical Education and Research;2024-06-21

3. New 2-oxoindole derivatives as multiple PDGFRα/ß and VEGFR-2 tyrosine kinase inhibitors;Bioorganic Chemistry;2024-04

4. Discovery of A Novel Series of Quinazoline–Thiazole Hybrids as Potential Antiproliferative and Anti-Angiogenic Agents;Biomolecules;2024-02-12

5. Exploration of the VEGFR-2 inhibition activity of phthalazine derivatives: design, synthesis, cytotoxicity, ADMET, molecular docking and dynamic simulation;RSC Advances;2024